← Leaderboards
Patrick M Stuart
Washington University
$5,780,919
Attributed
$5,780,919
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $386.4K · FY2005–14$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$5,780,919 · 4
By mechanism
R01$5,780,919 · 4
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- Megan T Baldridge$11,493,915
- William E Gillanders$14,751,159
- Ian F Korf$5,587,595
- Robert David Schreiber$32,299,425
- William G Hawkins$8,815,633
Others in their field
Top investigators on “Cornea”
- Raymond Kraker · Jaeb Center For Health Research, Inc.$47,584,981
- Ehud Isacoff · University Of California Berkeley$23,946,000
- Mary Ann Stepp · George Washington University$18,098,163
- Keri Hammel · The Emmes Company, Llc$17,992,237
- Reza Dana · Schepens Eye Research Institute$17,808,908
- Eric Pearlman · Case Western Reserve University$16,337,424
Research focus
CorneaKeratoplastyLaboratory MouseKeratitisApoptosisImmunotherapyCytokineImmuneIncidenceHomologous TransplantationCicatrixImmunosuppressionGenesHerpesvirus 1, HumanClinical ResearchHuman SubjectCountryEye TransplantationDesignCd95 MoleculeCellsBlindnessGene ExpressionInfection
Grant awards (19)
Mechanisms of HSK amelioration$330,750
R01 · FY2014 · EY · contact PI
Mechanisms of HSK amelioration$356,250
R01 · FY2013 · EY · contact PI
Mechanisms of HSK amelioration$375,000
R01 · FY2012 · EY · contact PI
Mechanisms of HSK amelioration$362,500
R01 · FY2011 · EY · contact PI
THE ROLE OF APOPTOTIC MOLECULES IN HERPETIC STROMAL$344,426
R01 · FY2010 · EY · contact PI
THE ROLE OF APOPTOTIC MOLECULES IN HERPETIC STROMAL$352,967
R01 · FY2009 · EY · contact PI
Amelioration of recurrent herpes keratitis$386,437
R01 · FY2007 · EY · contact PI
Amelioration of recurrent herpes keratitis$376,271
R01 · FY2006 · EY · contact PI
Amelioration of recurrent herpes keratitis$373,095
R01 · FY2005 · EY
Amelioration of recurrent herpes keratitis$361,247
R01 · FY2004 · EY
FAS L INDUCED APOPTOSIS IN CORNEA TRANSPLANTATION$53,550
R01 · FY2004 · EY
Amelioration of recurrent herpes keratitis$370,847
R01 · FY2003 · EY
FAS L INDUCED APOPTOSIS IN CORNEA TRANSPLANTATION$294,374
R01 · FY2003 · EY
FAS L INDUCED APOPTOSIS IN CORNEA TRANSPLANTATION$331,998
R01 · FY2002 · EY
FAS L INDUCED APOPTOSIS IN CORNEA TRANSPLANTATION$323,673
R01 · FY2001 · EY
AMELIORATION OF RECURRENT HERPES KERATITIS$229,200
R01 · FY2001 · EY
FAS L INDUCED APOPTOSIS IN CORNEA TRANSPLANTATION$64,855
R01 · FY2001 · EY
FAS L INDUCED APOPTOSIS IN CORNEA TRANSPLANTATION$269,390
R01 · FY2000 · EY
AMELIORATION OF RECURRENT HERPES KERATITIS$224,089
R01 · FY2000 · EY